SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-060550
Filing Date
2014-10-01
Accepted
2014-10-01 16:31:41
Documents
1
Period of Report
2014-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9995
  Complete submission text file 0001209191-14-060550.txt   11394
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CALITHERA BIOSCIENCES 343 OYSTER POINT BLVD, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Bennett Mark K (Reporting) CIK: 0001618163 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36644 | Film No.: 141133412